On March 11th, 2020, the outbreak of coronavirus disease 2019 (COVID-19) was declared a pandemic. Governments took drastic measures in an effort to reduce transmission rates and virus-associated morbidity. This study aims to present the immediate effects of the pandemic on patients presenting in the psychiatric emergency department (PED) of Hannover Medical School. Patients presenting during the same timeframe in 2019 served as a control group. A decrease in PED visits was observed during the COVID-19 pandemic with an increase in repeat visits within 1 month (30.2 vs. 20.4%, pBA = 0.001). Fewer patients with affective disorders utilized the PED (15.2 vs. 22.2%, pBA = 0.010). Suicidal ideation was stated more frequently among patients suffering from substance use disorders (47.4 vs. 26.8%, pBA = 0.004), while patients with schizophrenia more commonly had persecutory delusions (68.7 vs. 43.5%, pBA = 0.023) and visual hallucinations (18.6 vs. 3.3%, pBA = 0.011). Presentation rate of patients with neurotic, stress-related, and somatoform disorders increased. These patients were more likely to be male (48.6 vs. 28.9%, pBA = 0.060) and without previous psychiatric treatment (55.7 vs. 36.8%, pBA = 0.089). Patients with personality/behavioral disorders were more often inhabitants of psychiatric residencies (43.5 vs. 10.8%, pBA = 0.008). 20.1% of patients stated an association between psychological well-being and COVID-19. Most often patients suffered from the consequences pertaining to social measures or changes within the medical care system. By understanding how patients react to such a crisis situation, we can consider how to improve care for patients in the future and which measures need to be taken to protect these particularly vulnerable patients.
Die umfassende Neubearbeitung des Handbuches liefert kompakte und klare Informationen zu allen in Deutschland, Österreich und der Schweiz erhältlichen Psychopharmaka. Die Einteilung der Psychopharmaka erfolgt nach dem jeweiligen Anwendungsbereich. So werden u.a. Antidepressiva, Antipsychotika, Anxiolytika, Hypnotika, Phasenprophylaktika, Substanzen zur Behandlung der ADHS und des Substanzmissbrauchs, Antidementiva, missbräuchlich verwendete Substanzen und triebdämpfende Arzneimittel in all ihren psychopharmakologischen Eigenschaften und Wechselwirkungen dargestellt.
Im Buch wird mit verschiedenen Icons zu Indikationen und Kontraindikationen, Dosierung, Pharmakokinetik, unerwünschten Arzneimittelwirkungen, Absetzphänomenen, Hinweisen für die Pflege, Wechselwirkungen etc. gearbeitet. Leserinnen und Leser des Handbuches können dadurch schnell die für sie relevanten Informationen zu einem bestimmten Psychopharmakon auffinden. Auch nichtpharmakologische Therapieverfahren wie die Repetitive Transkranielle Magnetstimulation oder die Lichttherapie werden ausführlich behandelt. Zusätzlich zum Handbuch werden über 90 Seiten Patienteninformationen über häufig angewendete Psychopharmaka zur Verfügung gestellt, die nach erfolgter Registrierung von der Hogrefe Website heruntergeladen und den Patientinnen und Patienten mit nach Hause gegeben werden können. Dank der Übersichtlichkeit und leichten Zugänglichkeit der Informationen stellt das Handbuch ein praxisorientiertes und aktuelles Nachschlagewerk für alle im psychiatrischen Bereich tätigen Berufsgruppen dar.
Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.